Dusty punch cards and an eternal enigma: high-density lipoproteins and atherosclerosis

Kleber, Marcus E.; Grammer, Tanja B.; Kassner, Ursula; Silbernagel, Günther; März, Winfried (2014). Dusty punch cards and an eternal enigma: high-density lipoproteins and atherosclerosis. Drugs, 74(5), pp. 513-520. Adis International 10.1007/s40265-014-0189-5

Text art%3A10.1007%2Fs40265-014-0189-5.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (736kB) | Request a copy

Epidemiological, clinical, and experimental evidence has accumulated during the last decades suggesting that high-density lipoproteins (HDLs) may protect from atherosclerosis and its clinical consequences. However, more than 55 years after the first description of the link between HDL and heart attacks, many facets of the biochemistry, function, and clinical significance of HDL remain enigmatic. This applies particularly to the completely unexpected results that became available from some recent clinical trials of nicotinic acid and of inhibitors of cholesteryl ester transfer protein (CETP). The concept that raising HDL cholesterol by pharmacological means would decrease the risk of vascular disease has therefore been challenged.

Interest & Impact

Downloads

2 since deposited on 13 Oct 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item